Sartorius AG (XSWX:SRT3) Cyclically Adjusted Revenue per Share: CHF50.20 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:SRT3 Sartorius AG XSWX:SRT3
82 GF Score
Price CHF229.90
GF Value CHF226.51
! 6 Warning Signs
View Full Analysis

What is Sartorius AG Cyclically Adjusted Revenue per Share?

Sartorius AG XSWX:SRT3 82 Cyclically Adjusted Revenue per Share is CHF50.20 as of Jun. 2026. GuruFocus rates XSWX:SRT3 with a GF Score™ of 82/100 and a GF Value™ of CHF226.51. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sartorius AG's adjusted revenue per share for the three months ended in Jun. 2026 was CHF12.104. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF50.20 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Sartorius AG's average Cyclically Adjusted Revenue Growth Rate was 6.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sartorius AG was 20.20% per year. The lowest was 10.20% per year. And the median was 16.10% per year.

As of today (2026-09-04), Sartorius AG's current stock price is CHF229.90. Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was CHF50.20. Sartorius AG's Cyclically Adjusted PS Ratio of today is 4.58.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sartorius AG was 33.28. The lowest was 3.49. And the median was 7.68.


Sartorius AG  (XSWX:SRT3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sartorius AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=229.90/50.20
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sartorius AG was 33.28. The lowest was 3.49. And the median was 7.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sartorius AG Cyclically Adjusted Revenue per Share Related Terms


Sartorius AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sartorius AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG Cyclically Adjusted Revenue per Share Chart

Sartorius AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sartorius AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 52.51 50.20

XSWX:SRT3 vs ISRG, BDX, RMD: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PS Ratio falls into.


XSWX:SRT3
82GF Score
Sartorius AG XSWX:SRT3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius AG's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=12.104/131.3638*131.3638
=12.104

Current CPI (Jun. 2026) = 131.3638.

Sartorius AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.379 101.017 6.995
201612 5.328 101.217 6.915
201703 5.250 101.417 6.800
201706 5.642 102.117 7.258
201709 5.736 102.717 7.336
201712 6.418 102.617 8.216
201803 6.093 102.917 7.777
201806 6.671 104.017 8.425
201809 6.549 104.718 8.215
201812 6.905 104.217 8.704
201903 7.167 104.217 9.034
201906 7.485 105.718 9.301
201909 7.354 106.018 9.112
201912 7.569 105.818 9.396
202003 7.890 105.718 9.804
202006 8.641 106.618 10.647
202009 9.840 105.818 12.216
202012 10.416 105.518 12.967
202103 12.704 107.518 15.522
202106 13.366 108.486 16.185
202109 14.197 109.435 17.042
202112 14.114 110.384 16.797
202203 15.298 113.968 17.633
202206 15.502 115.760 17.592
202209 14.807 118.818 16.370
202212 15.334 119.345 16.878
202303 13.074 122.402 14.031
202306 11.875 123.140 12.668
202309 11.377 124.195 12.034
202312 11.714 123.773 12.432
202403 11.370 125.038 11.945
202406 11.731 125.882 12.242
202409 10.809 126.198 11.251
202412 12.263 127.041 12.680
202503 12.174 127.779 12.516
202506 11.995 128.412 12.271
202509 11.412 129.255 11.598
202512 12.535 129.361 12.729
202603 11.794 131.258 11.803
202606 12.104 131.364 12.104

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CHF50.20 mean?
Sartorius AG (XSWX:SRT3) has a Cyclically Adjusted Revenue per Share of CHF50.20 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sartorius AG and its competitors.
Is Sartorius AG's Cyclically Adjusted Revenue per Share too high?
Sartorius AG's current Cyclically Adjusted Revenue per Share is CHF50.20. Overall, Sartorius AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Sartorius AG's Cyclically Adjusted Revenue per Share of CHF50.20 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sartorius AG and its competitors. Sartorius AG's current Cyclically Adjusted Revenue per Share is CHF50.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Sartorius AG (XSWX:SRT3) has a current Cyclically Adjusted Revenue per Share of CHF50.20. The stock's GF Value™ is CHF226.51, compared to a current price of CHF229.90 — trading 1.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is CHF50.20. Sartorius AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sartorius AG (XSWX:SRT3), the current Cyclically Adjusted Revenue per Share is CHF50.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius AG (XSWX:SRT3) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be overvalued. The current stock price of CHF229.90 is trading 1.5% above its estimated GF Value™ of CHF226.51.

Key valuation signals for XSWX:SRT3:

  • Cyclically Adjusted Revenue per Share: CHF50.20
  • GF Value™: CHF226.51 vs. price of CHF229.90 (1.5% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the XSWX:SRT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
82GF Score

Get the complete analysis for XSWX:SRT3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF229.90
Price
CHF226.51
GF Value